Study reveals increasing rates of anaphylaxis-related hospital admissions and deaths in Brazil

Anaphylaxis, the most dangerous form of allergy, can result in fatality within minutes of exposure to an allergen. Data from high-income countries show that hospital admissions for anaphylaxis increased during the past 20 years, although numbers of fatalities did not increase. A report in Clinical and Experimental Allergy describes the first comprehensive evaluation of trends in anaphylaxis admissions and fatal anaphylaxis in a low or middle income country—in this case, Brazil.

Investigators found increasing rates of hospital admissions for anaphylaxis between 2011 and 2019 in Brazil, a middle-income country, which is similar to findings from high-income countries; however, they also found increasing fatal anaphylaxis rates.

Fatality rates were higher in Brazil than in most other national studies—more than 5% of people admitted to a hospital for anaphylaxis died, compared with approximately 1% in studies from high-income settings.

“These findings may influence officials in Brazil to facilitate wider availability of epinephrine devices such as EpiPens and other measures to protect people at risk of anaphylaxis,” said corresponding author Luciana Tanno, MD, PhD, of the University of São Paulo.

URL Upon Publication: https://onlinelibrary.wiley.com/doi/10.1111/cea.14193

Additional Information 

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact:

Dawn Peters +1 781-388-8408 (US)
newsroom@wiley.com
Follow us on Twitter @WileyNews

About the Journal

Clinical & Experimental Allergy is the Official Journal of the British Society for Allergy & Clinical Immunology, publishing clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part.Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field.

About Wiley

Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at  Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.